- Home
- PLAG vs SNGX Comparison
PLAG vs SNGX Comparison
Compare PLAG & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLAG
- SNGX
- Stock Information
- Founded
- PLAG 1986
- SNGX 1987
- Country
- PLAG United States
- SNGX United States
- Employees
- PLAG N/A
- SNGX N/A
- Industry
- PLAG Packaged Foods
- SNGX Biotechnology: Pharmaceutical Preparations
- Sector
- PLAG Consumer Staples
- SNGX Health Care
- Exchange
- PLAG Nasdaq
- SNGX Nasdaq
- Market Cap
- PLAG 6.6M
- SNGX 6.5M
- IPO Year
- PLAG N/A
- SNGX 1987
- Fundamental
- Price
- PLAG $0.87
- SNGX $1.41
- Analyst Decision
- PLAG
- SNGX
- Analyst Count
- PLAG 0
- SNGX 0
- Target Price
- PLAG N/A
- SNGX N/A
- AVG Volume (30 Days)
- PLAG 838.0K
- SNGX 2.5M
- Earning Date
- PLAG 08-13-2025
- SNGX 08-08-2025
- Dividend Yield
- PLAG N/A
- SNGX N/A
- EPS Growth
- PLAG N/A
- SNGX N/A
- EPS
- PLAG N/A
- SNGX N/A
- Revenue
- PLAG $6,066,143.00
- SNGX $2,342.00
- Revenue This Year
- PLAG N/A
- SNGX N/A
- Revenue Next Year
- PLAG N/A
- SNGX N/A
- P/E Ratio
- PLAG N/A
- SNGX N/A
- Revenue Growth
- PLAG N/A
- SNGX N/A
- 52 Week Low
- PLAG $0.47
- SNGX $1.26
- 52 Week High
- PLAG $5.52
- SNGX $14.83
- Technical
- Relative Strength Index (RSI)
- PLAG 34.50
- SNGX 31.69
- Support Level
- PLAG $0.75
- SNGX $1.26
- Resistance Level
- PLAG $0.94
- SNGX $1.52
- Average True Range (ATR)
- PLAG 0.34
- SNGX 0.12
- MACD
- PLAG -0.13
- SNGX -0.04
- Stochastic Oscillator
- PLAG 13.52
- SNGX 23.81
About PLAG Planet Green Holdings Corp.
Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).